Schizophrenia
Pipeline by Development Stage
Drug Modality Breakdown
On Market (23)
Approved therapies currently available
Competitive Landscape
46 companies ranked by most advanced pipeline stage
+16 more companies
Trial Timeline
Clinical trial activity over time
Showing 15 of 49 trials with date data
Clinical Trials (50)
Total enrollment: 7,083 patients across 50 trials
The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients
An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients
C-Cog in Early Course Schizophrenia Study
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode
A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia
A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia
A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics
Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia
Once-Daily Asenapine for Schizophrenia
A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone Palmitate
Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients
IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation
Efficacy and Safety of Paliperidone ER in First Episode Psychosis
Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia
Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER
A Phase 4 Study to Evaluate Response to Treatment and Safety of Paliperidone Extended-Release in Participants With Schizophrenia
Paliperidone Extended Release in Schizophrenia Participants With Duration of Illness Less Than 10 Years
Extended-Release Oxybutynin for the Treatment of Neurogenic Detrusor Overactivity
Efficacy Study on Cognitive Functions in Schizophrenic Patients
Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER)
A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With Schizophrenia
Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants
An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With Schizophrenia
Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With Schizophrenia
PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute Schizophrenia
Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease
An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment
Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward
Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia
Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet
Optimizing Response in Psychosis Study
Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia
A Placebo-Controlled, Cross-Over Trial of Aripiprazole
SOLIACS: Solian Solution in the Acute Setting
Amisulpride in Schizophrenic Acute Phase Patients
Valproate in Late Life Schizophrenia
Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety
Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder
Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy
Safety and Efficacy of Seroquel in First Episode Schizophrenia
Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Alcoholism and Schizophrenia: Effects of Clozapine
Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia
Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia
A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder
52-week Open Label Safety-Tolerability Study